Researchers make progress towards CRISPR-based microbiome editing
US researchers have engineered bacteriophages to deliver CRISPR-Cas payloads for targeted editing of a bacterium.
List view / Grid view
US researchers have engineered bacteriophages to deliver CRISPR-Cas payloads for targeted editing of a bacterium.
Researchers have found that beer hop compounds can inhibit the clumping of proteins associated with Alzheimer's disease.
A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defence mechanisms.
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
UPF and John Hopkins scientists have discovered how cancer cells exposed to high viscosity environments change their movements to improve their invasiveness and favour metastases.
Spanish researchers have discovered that vitamin C may hold the key to improving the efficacy of dendritic cell-derived anticancer therapies.
Streamline your cancer research using this guide that groups antibodies against critical cancer biomarkers according to biomarker type or tissue type.
MIT researchers have developed a technique that could help the production of monoclonal antibodies and other useful proteins.
Researchers from the University of California have developed the first pre-clinical model of appendiceal cancer, containing all elements of the tumour.
A recent study in mice revealed that an ion channel already proven to affect blood pressure in obese mice plays a role in suppressing their breathing, influencing sleep apnoea.
Researchers have used AI to design microneedle patches that restore hair in balding mice.
Tune in to this podcast to hear experts discuss 3D cell models, organoids and the automation of complex cell assays.
1 November 2022 | By Standard BioTools
Watch our on-demand webinar to hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.
A $1.2 million National Science Foundation grant funds project to use quantum AI to create effective pharmaceuticals faster and cheaper.
Researchers find monoclonal antibodies provided nearly complete protection against EBV infection and lymphoma when tested in mice.